Rate My Professor Gyan Modi

Dr. Gyan Prakash Modi serves as an Associate Professor in the Department of Pharmaceutical Engineering and Technology at the Indian Institute of Technology (BHU), Varanasi, a position he has held since November 2022, following his prior role as Assistant Professor in the same department from February 2016 to November 2022. His academic background includes a Ph.D. in Medicinal Chemistry from the Department of Pharmaceutical Sciences at Wayne State University, Detroit, Michigan, USA, completed from September 2009 to December 2013 with a minor in Organic Chemistry. He also obtained a Master of Pharmacy in Pharmaceutical Chemistry from the Institute of Technology, Banaras Hindu University, Varanasi, India, between August 2005 and August 2007, achieving a GPA of 8.3/10, with coursework at BHU and project work at the Central Drug Research Institute, Lucknow.

Dr. Modi's research specializations encompass the development of novel naturally inspired neuroprotective therapies for neurodegenerative disorders such as Alzheimer's disease, novel NIRF diagnostic agents, exploration of mechanism-based theranostic agents for Alzheimer's disease, novel NLRP3 inhibitors for central nervous system and cardiovascular disorders, and the design and synthesis of novel antibiotics with mechanistic evaluation. His career history includes a Postdoctoral Research Associateship at Brandeis University, USA, from February 2014 to January 2016 under Dr. Lizbeth Hedstrom, where he worked on repurposing IMPDH inhibitors for microbial infections, and a Visiting Research Scientist position at Brandeis University from February 2016 to February 2017. Among his major awards and honors are the Best Teacher Award at IIT (BHU) in the Undergraduate Engineering category for 2022, NIH Postdoctoral Fellowship from 2014 to 2016, Frank O. Taylor Award for outstanding scholarship and academic performance from the Department of Pharmaceutical Sciences at Wayne State University, SERB International Travel Support in 2018 for an EMBO workshop, and selection as a participant in the Young Investigator Meeting (YIM-2019) sponsored by IndiaBioscience and DBT, India. Key publications include "Discovery of novel NIRF theranostic probes targeting amyloid-β fibrils and cholinesterases in Alzheimer's disease models" (Nature Communications, 2026), "New D-π-A based coumarin-derived fluorescence theranostic probes with broad-spectrum antimicrobial activity" (Archiv der Pharmazie, 2025), "Design, synthesis and biological evaluation of caffeic acid-based novel multifunctional molecules for the management of Alzheimer's disease" (European Journal of Medicinal Chemistry, 2025), and "Design, Synthesis, and Biological Evaluation of Ferulic Acid Template-Based Novel Multifunctional Ligands Targeting NLRP3 Inflammasome for the Management of Alzheimer’s Disease" (ACS Chemical Neuroscience, 2024).